News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C news

Show

From To
Cancer
Statins tied to lowered liver cancer risk with hepatitis C

People infected with chronic hepatitis C are less likely to develop liver cancer if they are taking cholesterol-lowering drugs, new research from Taiwan suggests.

Published
9 hours ago
From
Reuters
Hepatitis C transmission and prevention
The New Deal: Gay Men, Sex, and Hep C

A new website has been launched, in order to provide gay men with information about sexual transmission of hepatitis C and how to prevent it; testing for and treatment of hepatitis C; and information about HIV and hepatitis C co-infection.

Published
21 March 2013
From
AFAO
New and experimental hepatitis C treatment
Sofosbuvir plus ribavirin works well for hard-to-treat inner-city hepatitis C patients

A simple 24-week oral regimen consisting of sofosbuvir plus full-dose ribavirin cured nearly 70% of previously untreated people with genotype 1 hepatitis C, many of whom had

Published
20 March 2013
By
Liz Highleyman
New and experimental hepatitis C treatment
AbbVie interferon-free combinations cure most newly treated hepatitis C patients

All-oral regimens consisting of the HCV protease inhibitor ABT-450, a non-nucleoside polymerase inhibitor and ribavirin led to sustained response for more than 90% of previously untreated hepatitis 

Published
20 March 2013
By
Liz Highleyman
Hepatitis C treatment
Roche’s Pegasys receives EU approval for the treatment of chronic hepatitis C in children five years of age and older

Roche announced today that the European Medicines Agency (EMA) has expanded the approval of Pegasys (peginterferon alfa-2a) plus ribavirin for the treatment of chronic hepatitis C virus (HCV). The new label includes children and adolescents five years of age and older, who have not received treatment and who have tested positive for the virus.

Published
19 March 2013
From
Roche press release
Hepatitis C
Even moderate alcohol consumption increases risk of death for people with chronic hepatitis C

Moderate alcohol consumption - as little as one or two drinks per day -  is associated with an increased risk of mortality for people with chronic

Published
18 March 2013
By
Michael Carter
Hepatitis C
Conference Highlights: EASL Monothematic Conference: HIV and the Liver

This was the first conference of its kind bringing together hepatologists and infectious disease specialists to address one of the critical issues in the management of HIV-infected patients: the rising mortality from liver disease. The Conference Highlights report features the key topics discussed and presented during the EASL Monothematic Conference. Email to a friend // // EASL would like to thank everyone who attended the EASL Monothematic Conference HIV and the Liver in London, UK, at the beginning of December 2012 and also thanks the European AIDS Clinical Society (EACS) for co-sponsoring the [...]

Published
14 March 2013
From
European Association for the Study of the Liver (EASL)
New and experimental hepatitis C treatment
Presidio Pharmaceuticals Announces Collaboration with Boehringer Ingelheim

The Parties to Initiate a Phase IIa Trial of an All-Oral Combination of Presidio’s HCV NS5A inhibitor (PPI-668) with Faldaprevir (BI201335) and BI207127 for the Treatment of Patients with Hepatitis C.

Published
13 March 2013
From
Presidio press release
Hepatitis C symptoms and diagnosis
Expanding High Risk Population Drives European Hepatitis B and C Diagnostics Market

New analysis from Frost & Sullivan, Analysis of the European Hepatitis B and C Diagnostics Market, estimates revenues of the hepatitis B diagnostics to grow from $165.9 million in 2012 to $260.2 million in 2019 and hepatitis C diagnostics market to grow from $3,140.8 million in 2012 to $4,940.9 million in 2019, respectively.

Published
13 March 2013
From
PR Newswire (press release)
New and experimental hepatitis C treatment
Adding telaprevir improves acute hepatitis C treatment for HIV-positive men

Adding telaprevir (Incivo or Incivek) to pegylated interferon and ribavirin shortens the duration of treatment and increases the likelihood of a cure for HIV-positive men with acute

Published
12 March 2013
By
Liz Highleyman
← First12345...59Next →

Filter by country